WC
INSM icon

Wexford Capital’s Insmed INSM Stock Holding History

Wexford Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-103,365
Closed -$2.06M – 129
2014
Q2 		$2.06M Sell
103,365
-154,660
-60% -$2.29M 0.15% 65
2014
Q1 		$4.91M Sell
258,025
-44,505
-15% -$846K 0.37% 40
2013
Q4 		$5.14M Buy
302,530
+201,440
+199% +$3.08M 0.44% 35
2013
Q3 		$1.58M Buy
+101,090
New +$1.28M 0.13% 91

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wexford Capital's INSM Position: Q3 2014 in Review

Wexford Capital sold out of Insmed (INSM) in Q3 2014, closing a stake of 103,365 shares — an estimated $2.06M sold.

Wexford Capital first reported a position in INSM in Q3 2013 and held it in 4 quarters. The position peaked at $5.14M in Q4 2013. 102 funds tracked by Wall St. Rank hold INSM as of Q3 2014.

  • Wexford Capital reported no remaining Insmed position as of Q3 2014 after selling out during the quarter.
  • Wexford Capital sold 103,365 Insmed shares in Q3 2014, an estimated $2.06M.
  • Wexford Capital first reported a position in Insmed in Q3 2013 and held it in 4 quarters.
  • Wexford Capital's Insmed position peaked at $5.14M in Q4 2013.
  • 102 funds tracked by Wall St. Rank held Insmed as of Q3 2014.

Based on Wexford Capital's 13F filing for Q3 2014, filed 13 Nov 2014.